Charles River & Millipore ally on viral clearance study technology
Charles River has partnered with EMD Millipore to improve the consistency of the viral clearance studies it offers clients.
Millipore is contributing its TrueSpike technology to the partnership. TrueSpike cell debris, DNA, and non-viral proteins to be removed from virus preparations used to validate manufacturing processes. Charles River Laboratories has exclusively licensed the TrueSpike technology.
“This partnership enhances our ability to exceed client expectations by offering a cost effective, innovative solution that accelerates the production and safety assessment”, Birgit Girshick, corporate vice president of biopharmaceutical Services at Charles River, said.
